IPO
Hong Kong biotech Prenetics tumbles after Nasdaq debut
CEO warns key COVID-19 testing business to drop as pandemic recedes
Health Care & Pharma
Pharmaceuticals
Indonesia's top drugmaker Kalbe Farma to boost ASEAN expansion
Philippine venture 'first step,' executive says, with Middle East on the horizon
Health Care
Hong Kong biotech Prenetics rides COVID wave to Nasdaq
Virus test provider helped soccer's Premier League resume play
Business deals
Ricoh jumps into mRNA pharmaceuticals with U.S. startup deal
Japanese printer maker targets capacity equivalent to 100m COVID shots by 2025
Pharmaceuticals
Nichi-Iko Pharma seeks debt restructuring aided by white knight
Scandal-hit Japan drugmaker opts for alternative dispute model
Pharmaceuticals
Japanese drugmakers reduce Russia business in wake of Ukraine war
They join global peers in pulling back as logistics, payment systems deteriorate
COVID vaccines
Japan pharma cranks up output of COVID vaccine materials
Global supplies shortage and dependence on West spell urgency, opportunity
Pharmaceuticals
Biogen CEO to step down as Eisai partner pulls back on Alzheimer's drug
Aduhelm was expected to be the company's next blockbuster but has faced doubts
Health Care
Japan Inc. bets on sleep tech to help reduce insomnia
Big names, startups race for ways to offer comfort, data and right mindset
Health Care
Sony gamifies home rehab with new medical venture
Smartphone app guides users through stroke recovery with help from AI
Pharmaceuticals
Sanofi moves up opening of Singapore vaccine plant to 2025
Drugmaker ushers in 'the future' with modular production and AI
Coronavirus
Shionogi in talks with U.S. to supply COVID oral drug
Japanese drugmaker also says vaccine proven effective in trials
Business deals
KKR-led group makes $14.8bn bid for Australia's Ramsay Health Care
Would mark country's biggest deal so far this year
COVID vaccines
Japan approves Novavax COVID vaccine, adding fourth option
Jab, different from Pfizer and Moderna's mRNA vaccines, provides 'diversity'
Trade
India's role in illicit synthetic drug trade draws closer scrutiny
Reports shed light on how cartels rely on supplies from across Asia
Pharmaceuticals
Eisai seeks accelerated FDA review of Alzheimer's drug
Quick approval sought despite Medicare's decision to limit coverage
Pharmaceuticals
The great medicines migration: How China controls key drug supplies
Western powers aim to reverse the industry's West-to-East shift
Pharmaceuticals
Takeda to give foreign directors two-thirds majority on board
Former U.S. EXIM Bank chief and veteran biotech exec nominated for seats
Health Care
South Korea senior care industry gets smart boost
Aging population sparks need for services but cost pressures limit profitability